U.S. Places Big H1N1 Vaccine Order With Australia’s CSL
This article was originally published in PharmAsia News
Executive Summary
Australia's CSL has received a $142 million order for H1N1 flu vaccine expected to be ready for inoculations in October. The order from the United States, where 12 deaths have been attributed to the disease, includes U.S. funding for clinical trials for the Novel A version of the disease in bulk form. CSL received an order for 10 million doses from the Australian government just days before. (Click here for more